MX351895B - Aplicacion terapeutica del aceite de krill parenteral. - Google Patents

Aplicacion terapeutica del aceite de krill parenteral.

Info

Publication number
MX351895B
MX351895B MX2013014901A MX2013014901A MX351895B MX 351895 B MX351895 B MX 351895B MX 2013014901 A MX2013014901 A MX 2013014901A MX 2013014901 A MX2013014901 A MX 2013014901A MX 351895 B MX351895 B MX 351895B
Authority
MX
Mexico
Prior art keywords
parenteral
krill oil
therapeutic application
oil
composition
Prior art date
Application number
MX2013014901A
Other languages
English (en)
Other versions
MX2013014901A (es
Inventor
F Driscoll David
Original Assignee
Stable Solutions Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US13/161,101 external-priority patent/US8895074B2/en
Application filed by Stable Solutions Llc filed Critical Stable Solutions Llc
Publication of MX2013014901A publication Critical patent/MX2013014901A/es
Publication of MX351895B publication Critical patent/MX351895B/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56Materials from animals other than mammals
    • A61K35/612Crustaceans, e.g. crabs, lobsters, shrimps, krill or crayfish; Barnacles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/46Ingredients of undetermined constitution or reaction products thereof, e.g. skin, bone, milk, cotton fibre, eggshell, oxgall or plant extracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/02Antidotes
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00General protective or antinoxious agents
    • A61P39/06Free radical scavengers or antioxidants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/06Antiarrhythmics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Toxicology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Insects & Arthropods (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Dispersion Chemistry (AREA)
  • Immunology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pain & Pain Management (AREA)
  • Vascular Medicine (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Dermatology (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Neurosurgery (AREA)
  • Botany (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

La presente invención se refiere a el uso del aceite de krill en una emulsión de aceite en agua para la manufactura de una composición parenteral para el tratamiento de varias condiciones clínicas, que comprende: un fosfolípido que contiene AG-n3, obtenido de aceite de krill, y un aceite de pescado que contienen un triglicérido que contienen AG-n3, en donde la composición comprende además al menos un fármaco, y en donde una parte del al menos un fármaco está presente en la fase oleosa de la emulsión y una pate de la misma al menos un fármaco en una sal soluble en agua está presente en la fase acuosa de la emulsión.
MX2013014901A 2011-06-15 2012-06-13 Aplicacion terapeutica del aceite de krill parenteral. MX351895B (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US13/161,101 US8895074B2 (en) 2011-06-15 2011-06-15 Therapeutic application of parenteral krill oil
EP11179821 2011-09-02
PCT/IB2012/001156 WO2012172411A1 (en) 2011-06-15 2012-06-13 Therapeutic application of parenteral krill oil

Publications (2)

Publication Number Publication Date
MX2013014901A MX2013014901A (es) 2014-07-09
MX351895B true MX351895B (es) 2017-11-01

Family

ID=46456944

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013014901A MX351895B (es) 2011-06-15 2012-06-13 Aplicacion terapeutica del aceite de krill parenteral.

Country Status (21)

Country Link
EP (1) EP2720701B1 (es)
JP (1) JP5864735B2 (es)
KR (1) KR101841588B1 (es)
CN (2) CN107648268B (es)
BR (1) BR112013032224B1 (es)
CA (1) CA2838312C (es)
CY (1) CY1119417T1 (es)
DK (1) DK2720701T3 (es)
ES (1) ES2643843T3 (es)
HR (1) HRP20171431T1 (es)
HU (1) HUE036720T2 (es)
IL (1) IL229690A (es)
LT (1) LT2720701T (es)
MX (1) MX351895B (es)
PL (1) PL2720701T3 (es)
PT (1) PT2720701T (es)
RS (1) RS56394B1 (es)
RU (1) RU2625760C2 (es)
SI (1) SI2720701T1 (es)
TW (1) TWI592160B (es)
WO (1) WO2012172411A1 (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2014262450A1 (en) 2013-05-10 2015-12-03 Memorial Sloan Kettering Cancer Center Lipid scavenging in Ras cancers
GB201402457D0 (en) 2014-02-12 2014-03-26 Aker Biomarine As Capsules containing high doses of phospholipids
GB201402450D0 (en) 2014-02-12 2014-03-26 Aker Biomarine As Liquid phospholipid-containing compositions for preperation of pharmaceuticals
GB201407345D0 (en) 2014-04-25 2014-06-11 Aker Biomarine As Krill Phospholipid compositions
PL3137070T3 (pl) * 2014-04-30 2020-07-13 Aker Biomarine Antarctic As Preparaty z oleju z kryla i ich zastosowania
EP3232798A1 (en) 2014-12-19 2017-10-25 Aker Biomarine Antarctic AS Enhanced omega-3 formulations
CN107567331A (zh) * 2015-03-31 2018-01-09 费森尤斯卡比德国有限公司 用于肠胃外给药的乳液
CN105901740A (zh) * 2016-04-26 2016-08-31 济南极源生物科技有限公司 一种南极磷虾油可食用营养品
SG11202000592WA (en) * 2017-08-10 2020-02-27 Childrens Medical Ct Corp Methods and compositions relating to emulsions comprising fish oil and/or omega-3 fatty acids
EP3536332A1 (en) * 2018-03-07 2019-09-11 Athenion AG Krill oil for solubilizing poorly water-soluble dietary supplements and pharmaceutically active agents
KR102451162B1 (ko) * 2020-09-07 2022-10-06 (주)에스디생명공학 효소처리 크릴 오일 추출물을 유효성분으로 포함하는 항염증, 피부 주름개선, 보습 및 피부 재생 촉진용 조성물

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9101642D0 (sv) * 1991-05-30 1991-05-30 Kabi Pharmacia Ab Phospholipids
JPH08231391A (ja) * 1995-02-24 1996-09-10 Kanagawa Kagaku Kenkyusho:Kk 痴呆症状改善薬
DE69842121D1 (de) * 1997-12-10 2011-03-17 Cyclosporine Therapeutics Ltd Omega-3 fettsäure enthaltende pharmazeutische zusammensetzungen
GB0012597D0 (en) * 2000-05-25 2000-07-12 Astrazeneca Ab Formulation
CN1516592A (zh) * 2001-06-18 2004-07-28 �����Ǽ���&������Դ���޹�˾ 用于预防和/或治疗心血管疾病、关节炎、皮肤癌、糖尿病、经前综合症和透皮转运的磷虾和/或海产提取物
US7666447B2 (en) * 2004-10-08 2010-02-23 Pharmanutrients Compositions including Krill extracts and conjugated linoleic acid and methods of using same
CN101321477A (zh) * 2005-10-07 2008-12-10 加拿大海洋营养食品有限公司 脂肪酸盐及其制备和使用方法
MX292557B (es) * 2006-11-16 2011-11-24 Pronova Biopharma Norge As Proceso para la produccion de fosfolipidos marinos ricos en omega-3 a partir de krill.
WO2008117062A1 (en) 2007-03-28 2008-10-02 Aker Biomarine Asa Bioeffective krill oil compositions
JP5443979B2 (ja) * 2007-05-11 2014-03-19 備前化成株式会社 新規のロイコトリエン受容体アンタゴニスト
NO327925B1 (no) * 2007-06-25 2009-10-19 Pharmalogica As Anvendelse av kullsyre i drikker omfattende polyumettede fettsyrer (PUFA) for a hindre oksidasjon av fettsyrene.
US20090099261A1 (en) * 2007-09-25 2009-04-16 Isi Brands Inc. Omega-3 mixtures
US20100062057A1 (en) * 2008-09-10 2010-03-11 Pronova BioPharma Norge AS. Formulation
US20100130619A1 (en) * 2008-11-24 2010-05-27 Joseph Schwarz Pharmaceutical composition for parenteral administration of idebenone
US8241672B2 (en) * 2009-03-11 2012-08-14 Stable Solutions Llc Omega-3 enriched fish oil-in-water parenteral nutrition emulsions
US20110071090A1 (en) * 2009-03-11 2011-03-24 Stable Solutions Llc Method of mitigating adverse drug events using omega-3-fatty acids as a parenteral therapeutic drug vehicle
NO333013B1 (no) * 2009-07-06 2013-02-18 Smartfish As Sammensetning omfattende bioaktive aminosyrer eller derivater derav og marin olje i en stabil olje-i-vannemulsjon, og fremgangsmate for fremstilling av nevnte sammensetning.
US8609157B2 (en) * 2009-10-30 2013-12-17 Tharos Ltd. Solvent-free process for obtaining phospholipids and neutral enriched krill oils

Also Published As

Publication number Publication date
CN107648268A (zh) 2018-02-02
KR20140053957A (ko) 2014-05-08
PL2720701T3 (pl) 2018-01-31
TW201302209A (zh) 2013-01-16
EP2720701A1 (en) 2014-04-23
RU2625760C2 (ru) 2017-07-18
IL229690A0 (en) 2014-01-30
BR112013032224A2 (pt) 2016-12-20
CN107648268B (zh) 2021-06-22
ES2643843T3 (es) 2017-11-24
TWI592160B (zh) 2017-07-21
RS56394B1 (sr) 2017-12-29
BR112013032224B1 (pt) 2021-10-13
MX2013014901A (es) 2014-07-09
DK2720701T3 (en) 2017-10-30
CY1119417T1 (el) 2018-03-07
EP2720701B1 (en) 2017-08-09
CA2838312A1 (en) 2012-12-20
CA2838312C (en) 2019-01-08
CN103608023A (zh) 2014-02-26
IL229690A (en) 2017-01-31
RU2014101067A (ru) 2015-07-20
KR101841588B1 (ko) 2018-03-26
PT2720701T (pt) 2017-10-23
HUE036720T2 (hu) 2018-07-30
LT2720701T (lt) 2017-11-10
SI2720701T1 (sl) 2017-12-29
HRP20171431T1 (hr) 2017-12-15
JP2014517028A (ja) 2014-07-17
WO2012172411A1 (en) 2012-12-20
JP5864735B2 (ja) 2016-02-17

Similar Documents

Publication Publication Date Title
MX351895B (es) Aplicacion terapeutica del aceite de krill parenteral.
EP2820286B8 (en) Oxygen-rich plasma generators for boosting internal combustion engines
MX342675B (es) Formulaciones estables para inyeccion parenteral de farmacos de peptido.
EP3143997A3 (en) Methods of administering pirfenidone therapy
MX2014004074A (es) Metodo de tratamiento de condiciones del higado utilizando antagonistas de notch2.
MX348933B (es) Composiciones, formas de dosificacion y coadministracion de un compuesto agonista opioide y un compuesto analgesico.
UA113962C2 (xx) Фармацевтична композиція, яка містить апоморфін як активний інгредієнт
IN2014DN07491A (es)
MX364220B (es) Metodos de tratamientos de fibrosis.
AR093632A1 (es) Tratamiento de cafe soluble
AR089320A1 (es) Cepa de lactobacillus mucosae
HK1203057A1 (en) Efficient lipid delivery to human tear film using a salt-sensitive emulsion system
CO7180190A2 (es) Copolimero basado en vinil-imidazolio cationico para separar una emulsión de petroleo en agua
MX345480B (es) Copolimero cationico basado en n-vinilpirrolidona para separar una emulsion de petroleo en agua.
NZ723918A (en) Methods for improving diaphragm function
UA68340U (ru) Способ производства вареной колбасы
UA63410U (ru) Профилактически-лечебный препарат «миметон-Н»
TH134727B (th) องค์ประกอบอิมัลชันแบบน้ำมันในน้ำและวิธีการสำหรับการผลิตเช่นเดียวกัน
UA74882U (uk) Фармацевтична композиція для лікування сексуальної дисфункції
UA80398U (ru) Способ региональной доставки глутатиона в слизистую кишечника
EE05665B1 (et) Kolbmootori kttesegu moodustamise meetod ja p?imtoitessteem
UA76186U (ru) Добавка диетическая "экстракт личинок восковой моли "галлерия мелонелла"
PH12014000105A1 (en) Therapeutic methods and compositions for treating diabetes utilizing diterpenoid compounds
UA64821U (ru) Способ медицинской реабилитации больных хроническим некалькулезным холециститом, соединенным с ожирением
UA69716U (ru) Способ приготовления эритроцитарных теней собаки

Legal Events

Date Code Title Description
FG Grant or registration